Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Non-Fasting Conditions

This study has been completed.
Information provided by:
Actavis Inc. Identifier:
First received: August 23, 2010
Last updated: NA
Last verified: August 2010
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2006
  Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)